Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Endocrine Connections
|
June 10, 2022
Endocrine and metabolic late effects following cancer treatment: challenges and controversies
Judith Gebauer, Claire E Higham
Pituitary
|
April 6, 2007
IGF-I measurements in the monitoring of GH therapy
Claire E Higham, Andreas Jostel, Peter J Trainer
Lancet (London, England)
|
April 5, 2016
Hypopituitarism
Claire E Higham, Gudmundur Johannsson, Stephen M Shalet
Endocrinology, Diabetes & Metabolism Case Reports
|
November 19, 2016
Hyponatraemia secondary to nivolumab-induced primary adrenal failure
Harris Trainer, Paul Hulse, Claire E Higham, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 13, 2026
Limitations and future directions in identifying risk factors for radiotherapy related pelvic insufficiency fractures in gynecological cancers: A scoping review
Artemis Bouzaki, Peter Hoskin, Claire E Higham, et al.
Endocrine Connections
|
April 25, 2023
Radiotherapy-related insufficiency fractures and bone mineral density: what is the connection?
Victoria Chatzimavridou-Grigoriadou, Lisa H Barraclough, Rohit Kochhar, et al.
The Cochrane Database of Systematic Reviews
|
April 24, 2018
Pharmacological interventions for the prevention of insufficiency fractures and avascular necrosis associated with pelvic radiotherapy in adults
Qurrat U van den Blink, Kate Garcez, Caroline C Henson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 11, 2020
Adjuvant immunotherapy: the sting in the tail
Claire E Higham, Viktoria Chatzimavridou-Grigoriadou, Cheryl T Fitzgerald, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 11, 2021
Clinical Experience of the Efficacy and Safety of Low-dose Tolvaptan Therapy in a UK Tertiary Oncology Setting
Victoria Chatzimavridou-Grigoriadou, Sami Al-Othman, Georg Brabant, et al.
European Journal of Endocrinology
|
March 4, 2025
Clinical impact of variations in laboratory measurements of growth hormone and insulin-like growth factor I on the classification of acromegaly disease activity status in the United Kingdom
Paul Benjamin Loughrey, John Ayuk, Bilal Bashir, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Endocrine Connections
|
June 10, 2022
Endocrine and metabolic late effects following cancer treatment: challenges and controversies
Judith Gebauer, Claire E Higham
Pituitary
|
April 6, 2007
IGF-I measurements in the monitoring of GH therapy
Claire E Higham, Andreas Jostel, Peter J Trainer
Lancet (London, England)
|
April 5, 2016
Hypopituitarism
Claire E Higham, Gudmundur Johannsson, Stephen M Shalet
Endocrinology, Diabetes & Metabolism Case Reports
|
November 19, 2016
Hyponatraemia secondary to nivolumab-induced primary adrenal failure
Harris Trainer, Paul Hulse, Claire E Higham, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 13, 2026
Limitations and future directions in identifying risk factors for radiotherapy related pelvic insufficiency fractures in gynecological cancers: A scoping review
Artemis Bouzaki, Peter Hoskin, Claire E Higham, et al.
Endocrine Connections
|
April 25, 2023
Radiotherapy-related insufficiency fractures and bone mineral density: what is the connection?
Victoria Chatzimavridou-Grigoriadou, Lisa H Barraclough, Rohit Kochhar, et al.
The Cochrane Database of Systematic Reviews
|
April 24, 2018
Pharmacological interventions for the prevention of insufficiency fractures and avascular necrosis associated with pelvic radiotherapy in adults
Qurrat U van den Blink, Kate Garcez, Caroline C Henson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 11, 2020
Adjuvant immunotherapy: the sting in the tail
Claire E Higham, Viktoria Chatzimavridou-Grigoriadou, Cheryl T Fitzgerald, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 11, 2021
Clinical Experience of the Efficacy and Safety of Low-dose Tolvaptan Therapy in a UK Tertiary Oncology Setting
Victoria Chatzimavridou-Grigoriadou, Sami Al-Othman, Georg Brabant, et al.
European Journal of Endocrinology
|
March 4, 2025
Clinical impact of variations in laboratory measurements of growth hormone and insulin-like growth factor I on the classification of acromegaly disease activity status in the United Kingdom
Paul Benjamin Loughrey, John Ayuk, Bilal Bashir, et al.
Page
of 3